|

Luminal Breast Cancer Cryoablation

RECRUITINGN/ASponsored by Lucía Graña López
Actively Recruiting
PhaseN/A
SponsorLucía Graña López
Started2026-03
Est. completion2028-09
Eligibility
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07447414

Summary

LUBRECA will evaluate the safety and efficacy of cryoablation with liquid nitrogen to treat cT1cN0 luminal breast cancer diagnosed in postmenopausal women

Eligibility

Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Postmenopausal women diagnosed with invasive breast cancer by core needle biopsy or vacuum-assisted biopsy
* Unifocal
* Lesion ≤ 2 cm (on ultrasound and contrast enhanced mammography)
* No axillary lymphadenopathy on ultrasound
* No axillary lymph node involvement on ultrasound.
* Luminal tumor (estrogen and/or progesterone receptor positive)
* HER2 negative
* Signed informed consent

Exclusion Criteria:

* Infiltrating lobular carcinoma
* Extensive in situ component
* Multifocality or multicentricity
* Contraindication for contrast mammography
* Not candidate for surgery
* Distant metastasis -

Conditions3

Breast CancerBreast Cancer, Early Breast CancerCancer

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.